Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

PAVmed (PAVM) Cost of Revenue (2020 - 2025)

PAVmed has reported Cost of Revenue over the past 5 years, most recently at $784000.0 for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 405.81% year-over-year to $784000.0; the TTM value through Dec 2025 reached $1.1 million, down 94.04%, while the annual FY2025 figure was $917000.0, 92.11% down from the prior year.
  • Cost of Revenue for Q4 2025 was $784000.0 at PAVmed, up from $55000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $12.8 million in Q4 2023 and troughed at $36000.0 in Q3 2024.
  • A 5-year average of $2.8 million and a median of $1.5 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 3188.89% in 2022 and later plummeted 98.79% in 2024.
  • Year by year, Cost of Revenue stood at $8.8 million in 2021, then plummeted by 34.19% to $5.8 million in 2022, then skyrocketed by 121.81% to $12.8 million in 2023, then plummeted by 98.79% to $155000.0 in 2024, then skyrocketed by 405.81% to $784000.0 in 2025.
  • Business Quant data shows Cost of Revenue for PAVM at $784000.0 in Q4 2025, $55000.0 in Q3 2025, and $41000.0 in Q2 2025.